volume 20, issue 2, PS95-S99 1992
DOI: 10.1007/bf01705025
View full text
|
Sign up to set email alerts
|
Share

Abstract: Infection during the period of bone marrow aplasia remains one of the major risks associated with high-dose chemotherapy and transplantation. Over the past several years, a number of investigators in Europe and North America have evaluated the use of GM-CSF in the setting of autologous bone marrow transplantation. These studies have almost all shown a hastening of myeloid engraftment. This, for the most part, has led to fewer serious infections and a decreased hospital stay for the GM-CSF treated patients. An …

Expand abstract

Search citation statements

Order By: Relevance

Citation Types

0
1
0

Paper Sections

0
0
0
0
0

Publication Types

0
0
0
0

Relationship

0
0

Authors

Journals